Related Experiment Video

Updated: Jul 22, 2026

Temporal Tracking of Cell Cycle Progression Using Flow Cytometry without the Need for Synchronization
08:52

Temporal Tracking of Cell Cycle Progression Using Flow Cytometry without the Need for Synchronization

Published on: August 16, 2015

Inhibition of bortezomib-induced apoptosis by red blood cell uptake

L M C Wheat, S L Kohlhaas, J Monbaliu

    Leukemia
    |June 23, 2006
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
    08:47

    Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation

    Published on: March 5, 2018

    Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
    13:19

    Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

    Published on: April 26, 2024

    Related Experiment Videos

    Last Updated: Jul 22, 2026

    Temporal Tracking of Cell Cycle Progression Using Flow Cytometry without the Need for Synchronization
    08:52

    Temporal Tracking of Cell Cycle Progression Using Flow Cytometry without the Need for Synchronization

    Published on: August 16, 2015

    Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
    08:47

    Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation

    Published on: March 5, 2018

    Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
    13:19

    Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

    Published on: April 26, 2024

    Related Concept Videos

    The Intrinsic Apoptotic Pathway01:31

    The Intrinsic Apoptotic Pathway

    Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...

    Articles linked to this work by shared authors, journal, and citation graph.

    Screening of IL-22 first and second introns and FOXP3 second exon for SNPs and mutations with potential role in the susceptibility of SLE in selected population.

    European review for medical and pharmacological sciences·2023

    Revolutionizing the effect of Azadirachta indica extracts on edema induced changes in C-reactive protein and interleukin-6 in albino rats: in silico and in vivo approach.

    European review for medical and pharmacological sciences·2023

    Molecular detection and prevalence of Rotavirus with acute gastroenteritis among the children of rural and urban areas.

    Brazilian journal of biology = Revista brasleira de biologia·2021

    Safety and tolerability of Transcutaneous Vagus Nerve stimulation in humans; a systematic review.

    Brain stimulation·2018

    Unusual diagnoses made by convex-probe endobronchial ultrasound-guided transbronchial needle aspiration.

    Pulmonology·2018

    The economic cost of stroke-associated pneumonia in a UK setting.

    Topics in stroke rehabilitation·2017

    Novel RNA polymerase I and cyclin-dependent kinase combination therapy for the treatment of aggressive acute myeloid leukemia.

    Leukemia·2026

    Measurable residual disease assessment as an early end point of treatment efficacy in acute myeloid leukemia: a multinational PETHEMA study of 2623 patients treated with intensive therapy.

    Leukemia·2026

    Generation of a novel knock-in mouse line expressing oncogenic Kit D814V in the hematopoietic stem cell compartment as a preclinical model for systemic mastocytosis.

    Leukemia·2026

    KT-253, a highly potent and selective MDM2 protein degrader, eliminates malignant myelofibrosis stem/progenitor cells.

    Leukemia·2026

    Venetoclax-based therapy versus hypomethylating agents alone in unfit patients with newly diagnosed acute myeloid leukemia: a real-world study from the PETHEMA registry.

    Leukemia·2026

    Chronic myeloid leukemia in a global context: confirmatory findings and novel discoveries from a refined Japanese Cohort.

    Leukemia·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us